Return On Capital Employed Overview: Regeneron Pharmaceuticals 2021-05-07T15:53:25-04:00May 7th, 2021| share this article! Regeneron Pharmaceuticals (NASDAQ:REGN) posted a 4.65% decrease in earnings from Q4. Sales, however, increased by 4.37% over the previous quarter to $2.53 billion. Despite the… Read More share this article! Related Posts Hershey Earnings Beat Driven by Higher Prices. Why Cocoa Fears Remain., Go to article May 3rd, 2024 Apple Stock Has a Relief Rally. But Big Long-Term Issues Remain., Go to article May 3rd, 2024 Cloudflare, Block, Fortinet, Palo Alto, and Other Tech Stocks in Focus Today, Go to article May 3rd, 2024 Coinbase Stock Falls After Earnings. Bitcoin Is Casting Dark Clouds., Go to article May 3rd, 2024
